购物车
- 全部删除
- 您的购物车当前为空
4E2RCat 是一种 eIF4E-eIF4G 相互作用的抑制剂,IC50为13.5 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
4E2RCat 是一种 eIF4E-eIF4G 相互作用的抑制剂,IC50为13.5 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 527 | 现货 | |
5 mg | ¥ 1,330 | 现货 | |
10 mg | ¥ 1,970 | 现货 | |
25 mg | ¥ 3,170 | 现货 | |
50 mg | ¥ 4,470 | 现货 | |
100 mg | ¥ 5,910 | 现货 | |
200 mg | ¥ 7,970 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,330 | 现货 |
产品描述 | 4E2RCat is an inhibitor of eIF4E-eIF4G interaction (IC50 = 13.5 μM) and is capable of blocking coronavirus replication as monitored by viral protein expression and the production of infectious virus. |
靶点活性 | eIF4E-eIF4G:13.5 μM |
体外活性 | 4E2RCat prevents the interaction between eIF4E (the cap-binding protein) and eIF4G (a large scaffolding protein), inhibiting cap-dependent translation. It significantly decreases human coronavirus 229E (HCoV-229E) replication, reducing the percentage of infected cells and intra- and extracellular infectious virus titers. 4E2RCat inhibits cap-dependent translation in a dose-dependent manner. 4E2RCat inhibits cap-dependent FF translation but not EMCV IRES-driven Ren translation. 4E2RCat inhibits coronavirus replication in a dose- and time-dependent manner[1]. |
体内活性 | 4E2RCat inhibits protein synthesis in vivo and it is not a consequence of increased cell death[1]. |
分子量 | 455.93 |
分子式 | C22H14ClNO4S2 |
CAS No. | 432499-63-3 |
Smiles | OC(=O)c1cc(ccc1Cl)-c1ccc(\C=C2/SC(=S)N(Cc3ccccc3)C2=O)o1 |
密度 | 1.56 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 15.5 mg/mL (34.00 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容